Popular Articles

Shire Presented Results Of A New Database Analysis On Lialda(R) (Mesalamine) And Other 5-ASAs For Ulcerative Colitis At Digestive Disease Week
Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, presented the results of a 5-aminosalicylic acid (5-ASA) persistency analysis entitled, "Twelve-month Persistence with 5-aminosalicylic Acid Therapy: Results from a Large Pharmacy Database," at Digestive Disease Week, on May 31, 2009. Results showed that after 12 months of therapy for continuing patients, 20 percent of Lialda patients were continually persistent, 9 percent of Asacol(R) (mesalamine) patients, 7 percent (250mg) and 10 percent (500mg) of Pentasa(R) (mesalamine) patients, 10 percent of balsalazide [combined results from generic balsalazide disodium and Colazal(R) (balsalazide disodium)] patients, and 10 percent (500mg) of Dipentum(R) (olsalazine sodium) patients were persistent. Continually persistent patients were defined as those who refilled their prescription within a period of up to twice the duration of the prescription that preceded the refill. Lialda is an FDA-approved, once-daily oral medication for the induction of remission in patients with active, mild to moderate ulcerative colitis (UC). Safety and effectiveness of Lialda beyond eight weeks have not been established.
generic viagra online
Tufts Health Plan Foundation Grant Awarded To Hebrew SeniorLife
Hebrew SeniorLife has received a $105,000 grant from the Tufts Health Plan Foundation for the expansion and implementation of three evidence-based healthy aging programs designed to disseminate preventive health-related information to seniors in the community.
News of the day
VA Medical Imaging Reaches Record Level
VistA Imaging, the medical and health care imaging system used in Department of Veterans Affairs (VA) medical centers, attained over one billion stored images in January this year, according to the department.
Mental Health

Palliative Care Research To Benefit From $1.5 Million Award

The American Cancer Society and the National Palliative Care Research Center (NPCRC) are awarding $1.5 million in research grants to researchers at eleven institutions for studies aimed at reducing suffering for seriously ill patients and their family caregivers. The studies will be conducted over the next two years. The NPCRC, in collaboration with the American Cancer Society, has directed over $5 million towards supporting 38 palliative care research projects since starting this initiative three years ago. "The physical and emotional symptoms that accompany chronic and serious illness like cancer cause so much suffering and yet have rarely been the focus of medical research or research funding" noted NPCRC Director R. Sean Morrison, M.D., who is also professor of Palliative Care, Geriatrics and Medicine at Mount Sinai School of Medicine. "It is my belief that if we are truly going to improve the quality of life for adults and children with chronic illness, then we need to focus our energies equally on disease specific treatments and on the physical, psychological, and emotional symptoms that accompany chronic illness and cause so much distress and suffering. Supporting evidenced-based research is a critical first step in the right direction," he noted. Palliative care focuses on relieving suffering and supporting the best possible quality of life for adults and children living with serious illness. It is a field comprised of doctors, nurses, social workers, and other specialists who care for patients with chronic illnesses, functional impairment, and a high burden of family caregiving responsibilities. It is provided at the same time as all other appropriate medical treatments. The collaborative initiative between the American Cancer Society and the National Palliative Care Research Center is designed to support clinician investigators conducting patient-oriented research in palliative care in hopes of bringing more funding from federal agencies, which have supported some research in palliative care, but for whom it is not a priority area. Pilot data results are typically needed before a federal agency will consider funding a research project. "It is encouraging to see the high caliber and innovative applications being submitted by professionals interested in conducting research in palliative care," said Ronit Elk, Ph.D., cancer control and prevention research program director in the extramural grants of the American Cancer Society. "This request for application (RFA) provides clinicians and researchers an opportunity to answer important questions they had long wanted to investigate, but without this unique funding opportunity had been unable to." "The American Cancer Society, in its initiative with the NPCRC, is making significant contributions towards reducing suffering caused by cancer and other serious illnesses," said Otis W. Brawley, M.D., chief medical officer of the American Cancer Society. "We strongly encourage other disease-specific organizations to follow suit and designate research dollars to further support research scientists who will advance the field of palliative care." The 2009 Grantees: NPCRC Pilot Project Support Grant Recipients Harvard Medical School - Jennifer W. Mack, M.D., MPH, an assistant professor of pediatrics at Dana-Farber Cancer Institute /Children"s Hospital Boston, will examine the interplay between hope, prognosis communication, and end-of-life decision-making in the pediatric oncology setting to find ways to improve how physicians communicate prognosis and support parents" hopes for their child"s end-of-life period. Ultimately, this work will help parents of children with advanced cancer make meaningful, value-driven decisions for their children"s lives and care. Northeastern Ohio Universities College of Medicine - Kyle R. Allen, D.O., professor of internal medicine and family medicine, and chief of the division of geriatric medicine and medical director of the Post Acute Senior Services Service Line at Summa Health System in Akron, Ohio, will conduct a randomized pilot study along with his co-investigator, Steven Radwany, M.D., medical director of hospice and palliative care at Summa Health System to determine the feasibility of a fully powered study to test the effectiveness of an in-home interdisciplinary palliative care case management intervention in improving a global measure of quality palliative care for consumers of Ohio"s community-based long-term care Medicaid waiver program, PASSPORT. American Cancer Society Pilot Project Support Grant Recipients University of North Carolina, Chapel Hill - Edwin B. Fisher, Ph.D., a professor in the department of health behavior and health education in the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill. Dr. Fisher"s research will describe how different types of support, including nondirective (cooperative) and directive (prescriptive) support may play key roles in quality of life among patients with advanced cancer or who are receiving palliative care. This will also lead to research to develop interventions that will improve quality of life for patients with advanced cancer and to develop guides or other res that will help their friends, family, and clinical teams to be more effective in providing them social support. University of Oklahoma Health Sciences Center - Marianne Matzo, Ph.D., a professor and the Frances E. and A. Earl Ziegler Chair in Palliative Care Nursing at The University of Oklahoma Health Sciences Center College of Nursing in Oklahoma City, Oklahoma, will focus on developing and pilot testing a coached communication intervention for sexual health promotion in women with recurring ovarian cancer (OVCA). This is a significant research area because it is an important concern of hospice patients which has not been well studied. This study will pave the way toward a larger, interventional study of palliative care patients and their sexual health. University of California, San Francisco - Michael Rabow, M.D., an associate professor of clinical medicine in the division of general internal medicine at the University of California, San Francisco, will evaluate the clinical efficacy, family caregiver outcomes, and health care utilization impacts of a surgical oncologic/palliative care co-management model for patients with bladder cancer to determine an intervention able to decrease suffering and improve well-being among bladder cancer patients and families. Elucidating the benefits of concurrent disease and symptom care may provide an innovative model that is broadly useful in the outpatient care of patients with other life-threatening cancers. Harvard Medical School - Jennifer Temel, M.D., an assistant professor of medicine at Harvard Medical School and an attending physician in thoracic oncology at Massachusetts General Hospital, will conduct a study to encourage oncology clinicians to discuss and document their patient"s goals of care and end-of-life care wishes. The intervention will involve an electronic reminder, sent via email, which contains pertinent information about the patients" disease and prognosis and res to assist the clinician with the conversation. Northwestern University, Feinberg School of Medicine - Jamie H. Von Roenn, M.D., a professor of medicine at Northwestern University, Feinberg School of Medicine, is a medical oncologist and expert in palliative medicine. She is Medical Director of the Palliative Care and Home Hospice Program at Northwestern Memorial Hospital and a full member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, will conduct a randomized study to examine the effects of a tailored physical therapy program on patients with advanced cancer newly hospitalized on the inpatient oncology unit for acute care. Such rehabilitation might maintain or improve these patients" physical function, compared to patients who receive the usual care. NPCRC Junior Faculty Career Development Award Recipients Harvard Medical School - Jane L. Givens, M.D., MCSE, an instructor of medicine within the division of gerontology at Beth Israel Deaconess Medical Center and Hebrew SeniorLife Institute for Aging Research will conduct one of the first detailed studies of family members of nursing home residents with advanced dementia to promote understanding of the mental health burdens facing over 4 million US families whose loved ones are experiencing the end-stage of dementia in nursing homes, and set the foundation for future research aimed at developing strategies to lessen that burden. Brown University - Ramona Rhodes, M.D., MPH, an assistant professor of medicine within the division of geriatrics at Lifespan/Rhode Island Hospital, Alpert Medical School, Brown University will conduct a study to improve hospice care for minorities. Specifically, she will describe and examine hospice-level variability associated with African Americans" perceptions of the quality of hospice services as well as identify processes of care and interventions that have resulted in improved quality of care for African Americans, through a nationwide survey of hospice providers. San Diego Hospice and Palliative Care - Scott A. Irwin, M.D., Ph.D., is an assistant clinical professor of psychiatry at University of California, San Diego, a diplomate of the American Board of Psychiatry and Neurology and is the Director of Psychiatry Programs at the Institute for Palliative Medicine at San Diego Hospice. Dr. Irwin will assess the feasibility of conducting a randomized, controlled, safety and efficacy trial of rapidly treating major depressive episodes with methylphenidate monotherapy in patients receiving hospice care. This trial will lay the groundwork for future multi-site randomized controlled trials in patients receiving hospice care and their caregivers, which are lacking for many psychiatric interventions used in this population. University

Pages: [1] 2 


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):